Ansan, South Korea

Yeong-Taek Park

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents. Top assignees: Dae Hwa Pharma. Co., Ltd., Daehwa Pharm. Co., Ltd.. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yeong-Taek Park. Retrieved from https://idiyas.com/inventor/yeong-taek-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 58(Granted Patents)


Location History:

  • Gyeonggi-Do, KR (2011)
  • Ansan-si, KR (2020 - 2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Yeong-Taek Park: Innovator in Pharmaceutical Compositions

Introduction

Yeong-Taek Park is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions that incorporate taxanes. With a total of five patents to his name, Park's work is recognized for its innovative approaches to drug formulation.

Latest Patents

Among his latest patents, Park has developed a pharmaceutical composition for oral administration that includes a taxane, medium chain triglycerides, and an oleoyl glycerol complex. This composition is designed to enhance the bioavailability of taxanes, which are crucial in cancer treatment. Another significant patent involves a high concentration taxane formulation, which comprises a specific percentage of taxane, medium chain triglycerides, monooleoyl glycerol, surfactants, and polyoxyl glyceryl fatty acid esters. These inventions aim to improve the effectiveness and ease of administration of taxane-based therapies.

Career Highlights

Throughout his career, Yeong-Taek Park has worked with reputable companies in the pharmaceutical industry, including Dae Hwa Pharma Co., Ltd. and Daehwa Pharm Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Park has collaborated with notable colleagues such as In-Hyun Lee and Min-Hee Son. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Yeong-Taek Park's innovative work in pharmaceutical compositions showcases his dedication to improving drug delivery systems. His contributions are vital in the ongoing efforts to enhance cancer treatment options through effective oral formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…